In this study, we employed a two-sample MR approach using publicly available genome-wide association study (GWAS) data to investigate the potential causal relationship between MS and COVID-19, as well as between MS treated by IFNβ and COVID-19. The gene discussed is IFNB1; the disease is COVID-19.